Turnover: ()

Country: France

SGD Pharma specializes in the manufacture of glass vials for the pharmaceutical industry.

With a production capacity of over 8 million vials a day, the company offers a wide range of products, including molded glass injectable vials, drawn glass injectable vials, infusions, ampoules, syringe vials, pillboxes, aerosols, etc.infusions, ampoules, syrup vials, pillboxes, aerosols, single-dose vials, dropper bottles and antibiotic vials with dipstick.

It also offers services such as lamination and printing, internal siliconizing, and a complete ready-to-use packaging and service solution.

The company has positioned itself as an industry leader thanks to its constant commitment to innovation. It offers its customers a wide range of pharmaceutical glass packaging solutions, adapted to different therapeutic needs.


SGD Pharma prepares its transition. 02/06/2023

  • SGD Pharma has specialized in pharmaceutical glass packaging since its foundation in 1917.
  • The Sucy-en-Brie site is the company's largest, with a presence on five continents.
  • More than 3 million containers leave the Sucy-en-Brie plant every day.
  • 60% of production at the Sucy-en-Brie plant is destined for Europe.
  • SGD Pharma employs 400 people at its Sucy-en-Brie site.
  • SGD Pharma invests in recycling to contain rising energy and raw material costs.
  • The plant's furnace 3 has undergone two plating operations after twelve years of service, and heats up to 1,600°C.
  • SGD Pharma had already purchased 80% of its annual stock of gas before the outbreak of war in Ukraine.
  • Dependence on lower production costs in Asia remains strong, although pharmaceutical control companies prefer European production.

Studies mentioning this company

> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)


Ask Sector-GPT  

Sector-GPT est la première IA dédiée aux informations sectorielles.